Skip to main content
. 2023 Nov 2;36(6):562–583. doi: 10.37201/req/115.2023

Table 3.

Situations in which the administration of directly observed anti-tuberculosis drugs (DOT) is considered a priority.

Treatment failures
Relapses
Drug resistance
Intermittent patterns
Previous poor adherence
Prior TB treatment or chemoprophylaxis
Indigence
Active or previous drug addiction (drugs, alcohol, ...)
HIV infection
Children and adolescents
Mental disturbances, cognitive impairment, psychological disturbances
Blindness, deafness and frailty
Institutionalized patients